—
C+
C+ The full Closelook — membership. Open the C+ overview

Pacific Biosciences of California (PACB) — Technical state

As of 2026-09-18 — re-computed nightly across the coverage universe. Closelook diary readings, not advice.

Recovery attempt under the 200-day

Trades +1.9% vs the 50-day and -14.3% vs the 200-day average, 49.8% below the 52-week high and +28% off the 52-week low. Computed from daily closes.

The moving-average stack

Continue: the PACB chart & overview · the signal board

FAQ · from the current data · as of 2026-09-18

Quick answers

What is the current Closelook signal on PACB?

Recovery attempt under the 200-day — Trades +1.9% vs the 50-day and -14.3% vs the 200-day average, 49.8% below the 52-week high and +28% off the 52-week low. Computed from daily closes. As of 2026-09-18; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is PACB above its 50-day and 200-day moving averages?

As of 2026-09-18, Pacific Biosciences of California trades +1.9% above its 50-day and -14.3% below its 200-day average, with the 20-day +0.6% away.

How far is PACB from its 52-week high?

49.8% below the 52-week high and 28% above the 52-week low, as of 2026-09-18.

Related in the Closelook universe

then Medical Devices. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.